Research Group receive Innovate UK ICURe SETsquared Award

We are delighted to be currently taking part in the UKRI Innovate UK ICURe SETsquared Cohort 32 (32-08 / 520268133: £30,000). This programme is allowing us to market validate our peptide hydrogel technology in a variety of applications both within drug delivery and the wider commercial landscape.

Our Research Associate Simon Porter is currently undertaking these activities remotely via conference attendance and engagement.

Further information on the programme can be found at the link below:

ICURe SETsquared Cohort 32

Related News


OUR RESEARCH IS FUNDED BY